Kezar Life Sciences Cash Flow Statement (2021-2025) | KZR

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -12.96M-14.46M-14.21M-16.02M-16.19M-17.85M-18.18M-22.20M-24.31M-23.10M-32.26M-21.66M-21.55M-20.31M-20.22M-16.56M-13.70M
Depreciation and Depletion 0.20M0.30M0.20M0.20M0.30M0.20M0.30M0.20M0.30M0.20M0.30M0.30M0.30M0.30M0.30M0.20M0.30M0.20M0.20M
Share-based Compensation 1.93M1.94M1.88M1.85M3.10M3.30M3.79M3.82M4.26M4.02M6.63M3.22M3.43M3.08M3.19M3.31M2.78M2.42M2.14M
Gains from Sales and Divestitures 0.01M0.01M0.13M0.13M0.02M0.02M0.01M
Gains from Investment Securities 0.04M7.31M6.89M-1.44M8.93M0.50M9.55M-0.01M3.00M12.96M13.33M15.26M1.72M-0.01M
Asset Writedowns and Impairment 2.70M1.50M
Non-cash Items 10.66M7.39M26.28M77.36M80.15M23.28M25.32M15.41M1.17M0.49M0.05M0.12M0.06M0.37M
Cash from Operations -8.36M-13.04M-9.95M-11.08M-13.31M-13.29M-16.36M-15.88M-20.86M-21.60M-20.20M-18.98M-22.86M-17.03M-17.49M-16.82M-17.19M-12.79M-9.83M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.51M-0.53M-0.41M-0.32M-0.34M-0.24M0.62M1.36M1.71M1.82M1.77M1.53M1.51M1.39M1.23M0.92M0.69M0.59M0.49M
Amortization of Deferred Charges 0.09M0.05M0.05M0.05M0.05M0.06M0.06M0.06M0.06M0.06M0.07M0.06M0.07M0.16M0.04M0.04M
Depreciation & Amortization (CF) 0.37M0.37M0.38M0.39M0.42M0.43M0.46M-0.28M0.26M0.25M0.28M0.28M0.26M0.26M0.26M0.26M0.25M0.24M0.23M
Change in Working Capital
Change in Accured Expenses 1.09M-1.66M1.73M0.06M-0.83M0.27M2.17M0.20M1.35M1.10M2.94M0.96M-3.01M-0.10M1.50M-1.54M-3.60M-2.73M-0.43M
Investing Activities
Capital Expenditures 0.02M0.15M0.26M0.45M0.18M0.60M0.34M1.23M0.44M0.14M0.00M0.02M0.01M0.01M
Change in Acquisitions & Divestments 25.50M28.00M43.75M31.00M15.44M69.25M72.45M85.25M70.75M55.75M54.00M77.75M37.75M47.00M44.05M42.99M13.75M39.73M30.00M
Cash from Investing Activities -0.69M16.25M38.48M-82.49M-59.53M1.51M-24.71M-8.66M16.39M13.20M18.57M27.88M20.41M12.22M24.06M23.74M13.74M11.40M15.71M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Repayments 1.30M1.30M1.30M
Change in Capital Stock
Shares Issued 0.06M0.28M1.16M0.58M0.21M0.42M0.18M0.51M0.15M131.70M0.04M131.70M0.06M
Misc.
Cash from Financing Activities 10.73M0.28M2.21M99.36M48.85M78.32M0.18M0.51M0.15M0.38M0.04M0.06M0.06M0.05M-1.30M-1.27M-1.30M
Exchange Rate Effect -0.01M-0.01M-0.03M0.00M0.03M-0.06M-0.05M0.04M-0.01M-0.01M-0.02M0.04M-0.01M0.00M0.02M-0.07M0.01M0.03M-0.01M
Change in Cash 1.68M3.47M30.71M5.79M-23.97M66.48M-40.93M-24.00M-4.33M-8.02M-1.61M8.99M-2.46M-4.76M6.58M6.89M-4.75M-2.63M4.57M
Free Cash Flow -8.36M-13.07M-10.11M-11.35M-13.76M-13.47M-16.96M-16.23M-22.09M-22.04M-20.34M-18.98M-22.86M-17.03M-17.51M-16.84M-17.20M-12.79M-9.83M
Net Cash Flow 1.69M3.49M30.74M5.78M-24.00M66.54M-40.88M-24.04M-4.32M-8.02M-1.59M8.96M-2.45M-4.76M6.57M6.97M-4.75M-2.67M4.58M